US stock market declines as Vaxcyte, Biohaven, and Moderna lead losses
US stocks closed sharply lower on March 31, 2025, led by biotech and tech losses. Learn why markets are reacting to tariffs, interest rates, and ... Read More
China discovers new bat coronavirus HKU5-CoV-2: How serious is the threat?
A newly identified bat coronavirus, HKU5-CoV-2, has been discovered by Chinese scientists, raising concerns about animal-to-human transmission and its potential public health implications. The virus ... Read More
HHS invests $590m in Moderna for mRNA-based pandemic influenza vaccines
The U.S. Department of Health and Human Services (HHS) has announced a monumental $590 million investment in Moderna, aiming to accelerate the development of mRNA-based ... Read More
First U.S. bird flu death sparks health concerns: What you should know
The United States has reported its first human fatality from the H5N1 avian influenza, a development raising critical public health questions. The victim, a Louisiana ... Read More
Merck invests $50m in Personalis to bolster Moderna collaboration on individualized cancer therapies
Personalis, Inc., a leader in precision oncology solutions, has secured a significant investment from Merck and extended its partnership with Moderna. These strategic agreements aim ... Read More
Is US facing new COVID-19 nightmare? KP.2 variant pushes hospitalization rates to record levels
The United States is grappling with the most severe COVID-19 surge since 2022, characterised by a sharp increase in hospitalisation rates and intensified viral activity. ... Read More
Moderna, Merck announce promising results for mRNA-4157 and Keytruda in melanoma
Moderna, Inc. (NASDAQ: MRNA) and Merck (NYSE: MRK), also known as MSD outside the United States and Canada, today revealed follow-up data from their collaborative ... Read More
Moderna, Merck get FDA breakthrough status for mRNA-4157/V940, KEYTRUDA combo in melanoma
Moderna and Merck announced that the investigational personalized mRNA cancer vaccine mRNA-4157/V940 in combination with the latter’s lung cancer drug KEYTRUDA (pembrolizumab) has been given ... Read More
Moderna to acquire Japanese biotech firm OriCiro Genomics for $85m
Moderna has agreed to acquire OriCiro Genomics, a Japanese biotech firm involved in developing cell-free synthesis and amplification of plasmid DNAs for applications in gene ... Read More
Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine
Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as ... Read More